End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.53 CNY | -2.86% | -0.85% | +25.36% |
Aug. 26 | Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
Jul. 11 | Yili Chuanning Biotechnology Gets Nod to Market Ursodeoxycholic Acid | MT |
Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | EV / EBITDA | EV / EBIT | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
+0.57% | +0.66% | 59x | 40.65 | 18.28x | 44.45x | 48.19x | 824B | ||
+1.27% | +1.67% | 39.55x | 27.72 | 13.77x | 28.05x | 31.13x | 595B | ||
+2.84% | +3.12% | 21.1x | 5.616 | 4.56x | 12.91x | 14.64x | 397B | ||
+3.22% | +3.33% | 37.68x | 40.93 | 7.14x | 15.43x | 16.01x | 342B | ||
+2.62% | +2.76% | 15.63x | 6.055 | 4.97x | 11.38x | 12.88x | 297B | ||
+3.68% | +3.78% | 16.05x | 5.860 | 3.79x | 9.8x | 11.02x | 254B | ||
+1.96% | +2.07% | 28.29x | 5.819 | 5.09x | 15.23x | 15.68x | 245B | ||
+3.26% | +3.38% | 21.55x | 5.270 | 4.96x | 12.57x | 13.25x | 235B | ||
+2.73% | +2.95% | 51.75x | 35.98 | 6.95x | 12.17x | 15.52x | 181B | ||
+5.61% | +5.72% | 21.78x | 1.917 | 3.72x | 10.06x | 12.22x | 168B | ||
+3.72% | +3.91% | 19.59x | 1.710 | 2.92x | 10.11x | 11.02x | 145B | ||
+3.66% | +3.85% | 311.66x | 5.364 | 4.39x | 12.06x | 16.4x | 104B | ||
+4.88% | +5.12% | -24.85x | 5.284 | 2.95x | 25.71x | 30.26x | 99.38B | ||
+3.83% | +4.07% | 12.34x | 4.063 | 2.41x | 7.14x | 8.26x | 85.24B | ||
+1.28% | +1.34% | 30.76x | 6.074 | 9.19x | 19.35x | 20.7x | 78.48B | ||
+1.22% | +1.48% | 43.46x | 5.628 | 4.68x | 26.88x | 35.07x | 65.91B | ||
+4.60% | +4.71% | 59.92x | 0.9276 | 2.43x | 10.17x | 36.47x | 47.33B | ||
+1.64% | +1.84% | 24.74x | 2.100 | 3.78x | 14.99x | 16.83x | 47.32B | ||
Average | +2.92% | +3.10% | 43.89x | 11.5 | 5.89x | 16.58x | 20.31x | 233.92B | |
Weighted average by Cap. | +2.39% | +2.57% | 40.47x | 19.39 | 8.77x | 21.50x | 24.09x |